Galapagos NV Receives EU2.3 Million IWT Grant For Fibrosis Research

Published: Feb 03, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MECHELEN, Belgium, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext: GLPG) announced today that it has been awarded a €2.3 million grant for research in fibrosis from the Flemish agency for Innovation by Science and Technology (IWT). The goal of this 2-year project is to create a new research platform by integrating knowledge from a range of fibrotic diseases, including lung, kidney, liver, and skin fibrosis. This new platform will support Galapagos' efforts to develop novel drug candidates in fibrosis.

Help employers find you! Check out all the jobs and post your resume.

Back to news